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ABSTRACT
Objective: To determine the acceptability, compliance and side effects of isoniazid (INH)
prophylaxis against tuberculosis among HIV infected police officers (PO) in Dar es Salaam.
Design: A nested study from a prospective follow up of a cohort of police officers.
Setting: Dar es Salaam, Tanzania.
Subjects: One hundred and forty three HIV-1 infected police officers.
Main outcome measures: Acceptance and compliance to INH prophylaxis.
Results: Of the 400 HIV-1 infected officers, 143 (35.7%) came forward for post-test
counselling and HIV test results. Sixty per cent (87/143) of them accepted to be on INH
prophylaxis. However only 42.5% (37/87) came forward for evaluation regarding their
suitability for INH prophylaxis. During the evaluation, eight (21.6%) of 37 otherwise
asymptomatic PO were found to have active pulmonary tuberculosis (TB). Eventually only
29 PO were actually started on INH, and only 16 (55.2%) of them completed the six months
course. No serious side effects were observed. One PO developed TB two months after loss
to follow up before completing the six months.
Conclusions: There was low acceptability of and poor compliance with INH prophylaxis
among the HIV-1 infected PO despite being educated on the benefits of prophylaxis. The
prevalence of PTB among asymptomatic HIV-1 infected PO was high, and therefore persons
with HIV infection should be examined for TB even in the absence of symptoms.
INTRODUCTION
With the advent of potent anti-tuberculosis drugs
more than three decades ago, it was hoped that tuberculosis
(TB), the dreaded disease as old as man’s history would
soon cease to be a public health problem; but that has not
happened. Until 1985 notified TB cases were decreasing,
but since then the trend was reversed with HIV attributable
TB cases ranging from 0 - 72% of reported TB cases
between 1985 - 1993 in sub - Saharan Africa(1,2). It is
estimated that the resurgence of TB would affect 90
million people by the year 2000(3).
In December 1998, the World Health Organisation
estimated that l3.9 million people had died of AIDS since
the beginning of the epidemic, more than 33 million were
still infected and eleven new infections were occurring
every minute(4). The HIV epidemic is particularly bad in
sub-Saharan Africa, which accounts for more than two
thirds of all infections in the world(5).
Data collected from antenatal clinics in Tanzania
during 1998 showed that 12 - 20% and 11- 24% of women
attending rural and urban antenatal clinic centres
respectively, were HIV infected(6). The prevalence of
HIV antibodies among patients with clinical TB in Tanzania
mainland ranged between 3 and 75.7% during 1998.
Furthermore, the Tanzania National AIDS Control
Programme (NACP) estimated that l40,000 new infections
occurred in mainland Tanzania during 1998 alone(6).
Consequently the pool of people with HIV infection is not
only a big one but is increasing rapidly.
The risk of developing tuberculosis (TB) disease
among HIV infected individuals and the association
between tuberculosis and AIDS has been well documented.
The incidence of tuberculosis in persons dually infected
with HIV-1 and M. tuberculosis is about eight to fifteen
per cent per year, representing a 30 -50% or greater
lifetime risk compared to ten per cent per lifetime in
immune competent persons with positive tuberculin
test(3,7). Indeed, HIV infection is the strongest known
risk factor for the development of tuberculosis(8). Active
tuberculosis develops much early during the course of
HIV infection and once it develops it accelerates the HIV
disease progression(9). TB chemoprophylaxis for patients
co-infected with HIV and M. tubeculosis is therefore of
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critical priority and has been recommended by the UNAIDS
and WHO(10). Prophylaxis with isoniazid (INH) has been
shown to reduce the incidence of TB in HIV infected
persons either by eradicating latent infection and or
preventing progression of new infection to active TB.
Whereas no drug toxicity from isoniazid was
encountered in the Haitian study(11), in Spain(12) nine
(11%) of eighty six of patients had to discontinue therapy
because of hepatotoxicity.
Adherence to tuberculosis preventive therapy among
HIV infected persons is variable among different
populations. In Thailand(14), it was reported to be 69.4%.
In a study conducted in Kampala, Uganda(15) high default
rates occurred at all stages between presentation to the
centre for voluntary counselling and provision of isoniazid
to HIV positive persons with positive tuberculin tests in
whom active disease had been excluded. In Mexico,
Garcia and colleagues found compliance to be acceptable
(90%) and frequency of side effects to be low(16).
In order to provide preventive therapy in developing
countries, there is need to address feasibility, sustainability,
cost effectiveness, methods of delivery, and monitoring
for exclusion of active tuberculosis, safety and
adherence(17). In addition, regular evaluation of persons
on preventive therapy is essential for detection of active
tuberculosis, safety and adherence.
Beginning 1994, a cohort of consenting police officers
in Dar es Salaam had been recruited to determine its
suitability for HIV vaccine trial. Police officers who tested
positive for HIV-1 antibodies were informed about their
increased risk of developing clinical tuberculosis, at the
time of giving the blood test results, and were invited to
participate in the INH prophylaxis study.
The study received ethical clearance from the National
AIDS Control Programme in the Ministry of Health, Dar
es Salaam and the Karolinska Institute, Stockholm, Sweden.
The aims of the study were to determine the
acccptability, compliance and side effects of INH prophylaxis
among HIV-1 infected Police Officers in Dar es Salaam.
MATERIALS AND METHODS
This was a nested study from a cohort being prepared for
possible HIV vaccine evaluation. At the beginning, all police
officers from different stations in Dar es Salaam were informed
about the study aims at their weekly meetings. Consenting
officers were pre-test counselled for HIV blood testing. During
post-test counselling visits, HIV -1 infected Police Officers were
informed of their risk of developing active TB disease and
potential benefits of isoniazid preventive therapy. Thereafter
they were invited to participate in the INH prophylaxis study.
Consenting officers were given an appointment to see one of the
internist in the study at the Muhimbili Medical Centre, where
participants were examined clinically and data was filled in a
questionnaire. Laboratory evaluation included sputum smear for
acid alcohol fast bacilli (AAFB), haemoglobin, white blood cell
count, and erythrocyte sedimentation rate (ESR). Tuberculin
skin test using two units Purified Protein Derivative (PPD) and
a postero-anterior chest roentgenograph were done to all patients.
A positive tuberculin reactivity was defined as an induration
≥5mm(18). Diagnosis of active tuberculosis was based on positive
sputum smears for AAFB. Patients with active TB were referred
to TB treatment centres; those free from active TB were started
on isoniazid 300 mg once daily for a duration of six months.
These clients were followed up monthly until they completed
the six months of treatment Thereafter they were followed up for
two years. During the follow up visits, development of side effects
was assessed based on history and physical examination.
Compliance was assessed by pill counting and adherence rate was
defined as taking more than 80% of the pills.
Data handling: Data were entered in a computer, analysis
was done using EPI 6 software. Chi squared test was used to
compare proportions and a p < 0.05 was considered significant.
RESULTS
General characteristics of study population: By the
end of December 1998, two thousand eight hundred and
ninety nine officers were enrolled in the main study, of
these 2782 (96%) accepted to be tested for HIV. Four
hundred (14.4%) were HIV-1 seropositive. The socio-
demographic characteristics of the subjects has been
reported elsewhere(19).
Isoniazid acceptability: Out of the 400 HIV infected
PO, 143 (35.7%) came forward for post-test counselling.
Among the counselled HIV seropositive PO, 87 (60.8%)
consented to take part in the isoniazid prophylaxis study;
while 56 (39.2%) refused (Table 1). Out of the 26 females
who came forward for post-test counselling, 17 (65.4%),
consented for INH prophylaxis as compared to 59.8% (70/
117) male PO (p=0.599). The socio-demographic
characteristics of PO consenting for INH and those
declining are shown in Table 2. The proportion of single
PO in the consenting officers (26.4%) was higher than
among the declining officers, (10.7%), p=0.02.
Significantly more extramarital sex was reported in the
consenting PO as compared to the declining PO, p=0.007.
Table 1
Acceptability if isoniazid prophylactic therapy among HIV seropositive police officers in Dar es Salaam
HIV+ ve Consented INH Initially screened Found with Started on INH Completed the Defaulted
for active TB active TB six months of
prophylaxis
N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Male 117 (76.5) 70 (80.0) 30 (81.1) 6 (75) 24 (82.8) 15 (78.9) 9 (90)
Female 26 (23.5) 17 (20.0) 7 (18.9) 2 (25) 5 (17.2) 4 (21.1) 1 (10)
Total 143 (100) 87 (100) 37 (100) 8 (100) 29 (100) 19 (100) 10 (100)
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Table 2
Socio-demographic characteristics among the isoniazid (INH)-
consenting and the INH-declining HIV seropositive police officers in
Dar es Salaam
Consented to INH Declined INH p-value
N=87 (%) N=56 (%)
Male 70 (80.5) 47 (83.9) 0.6
Female 17 (19.5) 9 (16.1) 0.6
Mean age (SD) 33 (6.2) 33.9 (7.0) 0.42
Marital status
Single 23 (26.4) 6 (10.7) 0.02
Married 62 (71.3) 50 (89.3) 0.01
Other 2 (2.3) –
Drinking alcohol 57 (65.5) 35 (62.5) 0.7
Extramarital sex
in the past 3 months 28 (32.2) 7 (12.5) 0.007
Condom use during
extramarital affair 2 (2.3) 7 (12.5) 0.035
However, out of the eighty seven police officers
consenting for prophylaxis with isoniazid, only 37 (42.5%)
eventually came forward to be evaluated for possible INH
preventive therapy. The mean haemoglobin concentration
among the study subjects was 12.97±1.76 g/dl; while the
total white blood cells count was 5400±1497 cells/mm3.
The mean erythrocyte sedimentation rate in the first hour
was 45.4±30.9 mm. Tuberculin skin test reactivity was
15.4% with a mean of 5.06±8.19 mm. The Mean Body
Mass Index was 18.6 (2.9) kg/m2, and BCG scar was
present in 19 officers, (17.1%). Herpes zoster scar was
present in three officers. Among the evaluated PO who
were otherwise asymptomatic, eight (21.6%) of the 37
officers were found to have active pulmonary tuberculosis
as evidenced by positive sputum smears. The
haematological indices on the evaluated PO showed no
statistically significant differences between subjects found
to have active TB and those without active disease.
Follow up and compliance: Twenty nine PO were
started on isoniazid for prevention of TB. Out of these,
only 19 officers (65.5%), completed the prescribed six
months course, and were fully compliant. Ten PO defaulted
from INH prophylaxis (Table 1). One Police Officer did
not come for follow up one month after enrolment and
developed active TB a month later; while another PO
developed active tuberculosis two years after completing
the six months of INH prophylaxis
Side effects: No side effects were observed on all PO
who were on preventive therapy and followed up for a
mean duration of two years.
DISCUSSION
The study has shown that despite intense education on
benefits of INH prophylaxis to HIV-1 infected police
officers, its acceptability was disappointingly low. Low
acceptability of INH among HIV infected has also been
reported from Uganda at all levels of recruitment to INH
preventive therapy(15). The low acceptability of INH in
this cohort of PO may to some extent be due to fear of
stigmatisation by peers or spouses if individuals are known
to be HIV infected through regular medical appointments
or regular use of medications as prolonged use of drugs is
associated with chronic ill health, and this may be linked
with HIV. Also the nature of police work is characterised
by unexpected emergencies, and these could have hindered
prospective HIV infected PO from showing up on the
appointment dates for assessment regarding INH use.
The proportion of single PO who consented for INH
prophylaxis was much higher than the declining ones.
This is probably because when an individual is single, then
he/she is not necessarily bound to reveal his/her HIV
status to anyone, and will thus feel more free to consent
and accept INH use. Similarly the proportion of INH
declining PO was higher among the married police officers.
Exposure or speculation about one's HIV status by a
spouse in a married relationship can easily be linked to
extramarital sexual affairs, a fact that may culminate in
marital disharmony or even a divorce. The fact that a
higher proportion of INH consenting PO reported
extramarital sexual contacts perhaps reflects the boldness
of these PO in being open regarding matters pertaining to
their private lives such as sex and HIV disease. It is
unlikely that effectiveness of counselling was a factor
here, as in all instances the involved counsellors were
physicians who were quite experienced in aspects of HIV
and had undergone specific training in HIV counselling.
We found adherence rate to be 65.5%. This is
comparable to what was found in other studies in Uganda
and Thailand where adherence rate was 69.4% and 62% in
Thailand(14) and Uganda(15) respectively but it was
much less than the 83.7% rate in the Mexican(16) study
where home visits were accomplished on non attending
subjects.
The number of active TB cases among asymptomatic
HIV seropositive PO was high in this cohort. This could be
attributable to immunosuppression by the HIV virus(20)
and probably also by the socio-environmental factors like
overcrowding in the police barracks as well as their places
of work, which favour transmission of M. tuberculosis
among the police. Observations in the National
Tuberculosis Programme clinics reveal that the proportion
of PO attending the various TB treatment centres in Dar es
Salaam is higher than the general population (Personal
communication). The finding of active TB in asymptomatic
HIV infected PO is of immense public health importance
as these cases will also pose a big threat to other workers
and family members in terms of being infected with M.
tuberculosis as reported previously(20,21). Screening
persons who are HIV seropositive for active TB even in
the absence of symptoms will thus identify the cases for
treatment and hence optimise TB control; and for those
cured of TB delay progression of their HIV disease.
There was no serious untoward effects observed in
these subjects put on INH prophylaxis, a finding similar to
the Haitian study(11).
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One case of active TB developed two years after
completing the six months of INH prophylaxis. This may
imply that six months of INH prophylaxis is inadequate
for preventive therapy and therefore, poses a crucial
question as to how long should the INH prophylaxis be
given in HIV infected individuals living in an area highly
endemic for tuberculosis. Life-long prophylaxis seems
more appropriate. Clearly more studies are required to
resolve this issue.
Tuberculin skin reactivity was low in this group of
patients, however, INH prophylaxis was offered to all
consenting HIV infected PO with no active TB regardless
of their tuberculin skin reactivity since it is presumed that
more than 80% of our general population is known to be
primarily infected with M. tuberculosis(6).  This is
especially important when the reactivity to other recall
antigens was not done, and that immune suppression by
HIV could have affected tuberculin reactivity.
In conclusion, there was low acceptability of INH
prophylaxis among the HIV-1 infected officers despite
being educated on the importance of INH prophylaxis. It
follows that the operational aspect of providing INH
prophylaxis in HIV infected individual calls for extreme
care, vigilance and far more efforts than one may expect
including consideration to undertake home visiting for
those declining participation. The high prevalence of PTB
among asymptomatic HIV seropositive PO also stresses
the importance of actively searching for tuberculosis in all
HIV infected individuals, even if asymptomatic, especially
in communities where both HIV and tuberculosis co-exist.
Further studies are needed to address important questions
of reasons for low acceptability; and optimal duration of
INH prophylaxis among HIV infected patients.
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